US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
(OP:
BIOE
)
0.4700
UNCHANGED
Last Price
Updated: 9:30 AM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BIOE
Bio Essence Unveils Practitioner-Controlled Knowledge Vault, Tackling AI's Trust Barrier in Healthcare
October 29, 2026
First milestone in the MediFlow Practitioner AI initiative puts practitioners - not algorithms - in control of their professional knowledge.
From
Bio Essence Corp.
Via
ACCESS Newswire
Bio Essence Corp Appoints Xiying (Thea) Zhang and Geoff Fellows as Independent Directors to Its Board
October 26, 2026
Board expands from three to five members, a majority of whom are now independent; new directors bring deep operations, finance and governance expertise
From
Bio Essence Corp.
Via
ACCESS Newswire
Bio Essence Corporation Expands MediFlow Platform with Development of Practitioner-Specific AI and RAG Technology
October 15, 2026
New development initiative is designed to add practitioner-specific AI, secure knowledge management and retrieval-augmented generation capabilities to MediFlow.
From
Bio Essence Corp.
Via
ACCESS Newswire
Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio
April 27, 2026
Via
ACCESS Newswire
BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026
March 03, 2026
Via
ACCESS Newswire
BIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million
February 03, 2026
Via
ACCESS Newswire